Suchergebnisse - "Porcari, Aldostefano"

PubPharm (7)

1

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy

enthalten in: Global heart | 2023

von Fontana, M. | Porcari, A. | Hawkins, P.

2

Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis

enthalten in: ESC heart failure | 2022

von Castrichini, M. | Porcari, A. | Baggio, C. | +7

3

Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis

enthalten in: European journal of heart failure | 2022

von Patel, R. | Ioannou, A. | Razvi, Y. | +22

CommentIn: Eur J Heart Fail. 2022 Dec;24(12):2364-2366. - PMID 36059061

4

Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis

enthalten in: European journal of heart failure | 2022

von Tomasoni, D. | Aimo, A. | Merlo, M. | +16

CommentIn: Eur J Heart Fail. 2022 Dec;24(12):2387-2389. - PMID 36066359

5

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

enthalten in: European journal of heart failure | 2022

von Chacko, L. | Karia, N. | Venneri, L. | +29

CommentIn: Eur J Heart Fail. 2022 Sep;24(9):1713-1715. - PMID 35906799

6

Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery

enthalten in: ESC heart failure | 2022

von Porcari, A. | Pagura, L. | Longo, F. | +9

7

High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients

enthalten in: International journal of cardiology | 2021

von Paldino, A. | De Angelis, G. | Dal Ferro, M. | +11

CommentIn: Int J Cardiol. 2021 Jan 15;323:201-202. - PMID 33131687

1
[1]